Basal cell carcinoma is the most common skin cancer. Fair-skinned people have the highest risk of developing basal cell carcinoma. It mainly affects older people who have been exposed to the sun for many years. Unfortunately, basal cell carcinomas are increasingly occurring in younger patients as a result of changing leisure habits. In addition to permanent exposure to light, exposure to arsenic (formerly used in viticulture and to treat psoriasis), immunosuppression in organ transplant recipients, radioactive radiation, radiation treatments and rare hereditary diseases. Basal cell carcinomas are malignant skin tumors which, if they grow unchecked, destroy adjacent structures and can thus cause great damage. In contrast to black skin cancer, there is usually no fear of colonization. However, the malignancy of this tumor becomes particularly clear when it grows on the face and can endanger and destroy the eye or nose, for example.
The first step in therapy is the surgical removal of the tumor. This is carried out by us in accordance with the guidelines. All tumors are examined histologically (histologically). On the face, in the case of recurring tumors and at problem locations, the operation is micrographically controlled. Photodynamic therapy (PDT), cryotherapy and local chemotherapy and immunotherapy can also be used for flat basal cell carcinomas on the trunk and extremities.
Radiation therapy may be the treatment of choice for inoperable tumors. We work together with a corresponding clinic.